Results 241 to 250 of about 46,422 (312)

Incretin mimetics for weight loss forgive nonadherence

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims GLP‐1 and GIP‐GLP‐1 agonists have emerged as potent weight‐loss medications. These incretin mimetics often have low patient adherence, and as with any medication, clinically meaningful efficacy requires adequate adherence. But what constitutes “adequate” adherence for incretin mimetics?
Anıl Cengiz   +2 more
wiley   +1 more source

Pharmacological interventions for co-occurring psychopathology in people with borderline personality disorder: secondary analysis of the Cochrane systematic review with meta-analyses. [PDF]

open access: yesBr J Psychiatry
Pereira Ribeiro J   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy